224 related articles for article (PubMed ID: 11280804)
1. Up- and down-regulation of granulocyte/macrophage-colony stimulating factor activity in murine skin increase susceptibility to skin carcinogenesis by independent mechanisms.
Mann A; Breuhahn K; Schirmacher P; Wilhelmi A; Beyer C; Rosenau A; Ozbek S; Rose-John S; Blessing M
Cancer Res; 2001 Mar; 61(5):2311-9. PubMed ID: 11280804
[TBL] [Abstract][Full Text] [Related]
2. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells.
Obermueller E; Vosseler S; Fusenig NE; Mueller MM
Cancer Res; 2004 Nov; 64(21):7801-12. PubMed ID: 15520186
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
[TBL] [Abstract][Full Text] [Related]
4. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
[TBL] [Abstract][Full Text] [Related]
5. Targeted expression of human O(6)-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis.
Becker K; Dosch J; Gregel CM; Martin BA; Kaina B
Cancer Res; 1996 Jul; 56(14):3244-9. PubMed ID: 8764116
[TBL] [Abstract][Full Text] [Related]
6. The effect of cyclooxygenase-2 overexpression on skin carcinogenesis is context dependent.
Rundhaug JE; Pavone A; Kim E; Fischer SM
Mol Carcinog; 2007 Dec; 46(12):981-92. PubMed ID: 17583568
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion.
Robertson FM; Bijur GN; Oberyszyn AS; Pellegrini AE; Boros LG; Sabourin CL; Oberyszyn TM
Carcinogenesis; 1994 May; 15(5):1017-29. PubMed ID: 8200063
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
[TBL] [Abstract][Full Text] [Related]
9. Epidermal overexpression of granulocyte-macrophage colony-stimulating factor induces both keratinocyte proliferation and apoptosis.
Breuhahn K; Mann A; Müller G; Wilhelmi A; Schirmacher P; Enk A; Blessing M
Cell Growth Differ; 2000 Feb; 11(2):111-21. PubMed ID: 10714767
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion.
Reddig PJ; Dreckschmidt NE; Zou J; Bourguignon SE; Oberley TD; Verma AK
Cancer Res; 2000 Feb; 60(3):595-602. PubMed ID: 10676642
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells.
Armstrong CA; Botella R; Galloway TH; Murray N; Kramp JM; Song IS; Ansel JC
Cancer Res; 1996 May; 56(9):2191-8. PubMed ID: 8616871
[TBL] [Abstract][Full Text] [Related]
13. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
[TBL] [Abstract][Full Text] [Related]
14. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase.
Lu YP; Lou YR; Yen P; Newmark HL; Mirochnitchenko OI; Inouye M; Huang MT
Cancer Res; 1997 Apr; 57(8):1468-74. PubMed ID: 9108447
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
Jhappan C; Takayama H; Dickson RB; Merlino G
Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512
[TBL] [Abstract][Full Text] [Related]
16. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion.
DiGiovanni J; Bol DK; Wilker E; Beltrán L; Carbajal S; Moats S; Ramirez A; Jorcano J; Kiguchi K
Cancer Res; 2000 Mar; 60(6):1561-70. PubMed ID: 10749124
[TBL] [Abstract][Full Text] [Related]
17. Epidermal Langerhans cells from mice bearing a granulocyte macrophage-colony stimulating factor-producing mammary tumor display impaired accessory functions.
Xie Y; Fernandez ME; Streilein JW; Lopez DM
Anticancer Res; 1996; 16(1):9-16. PubMed ID: 8615675
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Reddig PJ; Dreckschmidt NE; Ahrens H; Simsiman R; Tseng CP; Zou J; Oberley TD; Verma AK
Cancer Res; 1999 Nov; 59(22):5710-8. PubMed ID: 10582689
[TBL] [Abstract][Full Text] [Related]
19. Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.
Toda M; Martuza RL; Rabkin SD
Mol Ther; 2000 Oct; 2(4):324-9. PubMed ID: 11020347
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1alpha up-regulation in vivo by a potent carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) and control of DMBA-induced inflammatory responses.
Li X; Eckard J; Shah R; Malluck C; Frenkel K
Cancer Res; 2002 Jan; 62(2):417-23. PubMed ID: 11809690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
